In the evolving field of cel Vitronectin is a large glycoprotein found in blood and the extracellular matrix (ECM). The gene for vitronectin encodes a 19 amino acid (aa) signal peptide and l biology and tissue engineering, the vitronectin peptide has emerged as a significant area of interest for researchers focused on substrate development and cellular interaction. As someone deeply invested in the technical aspects of laboratory research and peptide synthesis, I have spent considerable time analyzing how fragments of this multifunctional glycoprotein can be utilized to optimize experimental environments.
Understanding the Vitronectin Molecule
Vitronectin is a complex, 70 kDa glycoprotein found in both serum and the extracellular matrix (ECM). It is a well-documented member of the hemopexin family and serves as a vital cell adhesion and spreading factor. Because it is essential for maintaining the integrity and normal function of tissues, it has become a gold standard for those looking to create a defined environment for cell cultures.
When we talk about the vitronectin peptide, we are generally referring to a fragment or bioactive sequence derived from the vitronectin protein itself. These smaller, synthetic versions are often preferred in controlled laboratory settings because they offer a more predictabl Vitronectin in health and disease: Mechanisms and therapeutic e, animal-free, synthetic, flexible vitronectin-based peptide substrate compared to the full-length protein extracted from biological sources.
Key Research Applications
The versatility of these peptides is reflected in how they are currently being applied in high-level research:
* Cell Differentiation and Adhesion: Researchers often utilize these fragments to provide a new defined coating material for the differentiation of various cell types, including oligodendrocytes (ODs) from human pluripotent stem cells.
* Osteoblast Activity: Studies have shown that specific bioactive core sequences, such as VnP-16, have promoted bone formation by accelerating o by L Cassari · 2023 · Cited by 16 — In this work, the surfaces of 3D-printed. PEEK disks were functionalized with: (i) an adhesive peptide reproducing [351–359] h-Vitronectin. steoblast differentiat 16 May 2026 — Vitronectin is a key extracellular matrix glycoprotein, but the functional contribution of specific residues within its N‐terminal region to ion and activity, offering a fascinating look at how lo by L Cassari · 2023 · Cited by 16 — In this work, the surfaces of 3D-printed. PEEK disks were functionalized with: (i) an adhesive peptide reproducing [351–359] h-Vitronectin. calized signaling can impact tissue-level development.
* Scalable Substrates: The development of a robust vitronectin-derived peptide has proven essential for the scalable long-term expansion of stem cells. By utilizing an easy-to-use, xeno-free, defined, recombinant human ECM, laboratories can achieve more consistent results without the variability associated with undefined serum-based reagents.
Technical Specifications and Structural Considerations
From a structural perspective, the VTN (Vitronectin) gene encodes a protein that is synthesized in the liver and secreted into the bloodstream. It is well-known that the vitronectin peptide, such as the [351–359] h-Vitronectin sequence, can be used to functionalize surfaces like 3D-printed PEEK disks to improve biocompatibility.
When sourcing these materials, it is important to note the specific characteristics of the peptide. For instance, the Vitronectin (367-378) fragment is frequently studied for its Recombinant N‐terminal Fragment of Human Vitronectin role in cell growth and its interaction with integrins. Whether you are working with a VTN/Vitronectin His Tag Protein or a specific amino acid fragment, the purity and the specific sequence design are paramount to the success of the experiment.
Observations on Laboratory Usage
In my own experience with these compounds, the transition toward a synthetic, xeno-free alternative has been a game-changer. By using a frag PluriSTEM™ Recombinant Vitronectin is an effective xeno-free alternative to matrigel™ and has been validated to successully culture human ES and iPS cells using ment that mimics the native protein, we eliminate the risks associated with xenogenic contaminants. It is fascinating to see how a simple sequence—a fragment or bioactive sequence derived from the vitronectin protein—can replicate the complex adhesive properties of the native molecule.
Furthermore, because vitronectin is a member of the pexin family, its structural stability is generally high, making it an excellent candidate for coating plates or flasks. Whether you are investigating the role of VTN as a plasma glycoprotein or attempting to induce specific cellular pathways, the precision offered by these engineered peptides is unmatched.
Conclusion
The study of the vitronectin peptide continues to push the boundaries of what is possible in regenerative research. By isolating the functional characteristics of this glycoprotein, we are a VTN Gene - GeneCards | VTNC Protein | VTNC Antibody ble to create more refined, reproducible, and efficient experimental models. As research progresses, the ability to tailor these sequences to specific cellular needs will undoubtedly remain a cornerstone for those focused on the mechanics of cell adhesion and the fundamental architecture of the extracellular matrix.